glp-1 gonzales FDA grants the first approval for liver disease treatment UF researchers demonstrate GLP-1RAs' potential

Kageyama T, Nakamura M, Matsuo A, Yamasaki Y, Takakura Y, Hashida M, Kanai Y, Naito M, Tsuruo T, Minato N, Shimohama S

Skin Solutions: Microdart patches effectively deliver active ingredients to trouble spots

Because the protein fractions are sensitive to heat and aggressive blending, gentle mixing is recommended

5 The recent rise in the demand for GLP-1RAs has led to unexpected drug shortages that have prevented patients who typically use these medications for glycemic management, weight loss, and/or cardiovascular risk reduction from experiencing new challenges in their access to GLP-1RAs

A high-throughput screen reveals new small-molecule activators and inhibitors of pantothenate kinases